March 17, 2009 - The American Society for Radiation Oncology (ASTRO) said that Calypso Medical, Standard Imaging and Varian Medical Systems have been elected to serve three-year terms on ASTRO's Corporate Advisory Council.

PTW New York was also elected to serve the balance of a term vacated by Carestream Health. These companies were elected by ASTRO's corporate membership and were approved by the ASTRO Board of Directors.

"It is very important for ASTRO to maintain a good working relationship with our industry partners as these companies continue to innovate tools that help our physician members use radiation therapy to treat and cure people living with a diagnosis of cancer," said Hak Choy, M.D., chair of ASTRO's corporate relations committee and a radiation oncologist at the University of Texas Southwestern Medical Center in Dallas. "We believe that fostering this forum helps our society successfully connect the patient, doctor and industry in targeting cancer care."

The Corporate Advisory Council is a representative body of ASTRO's corporate membership, consisting of nearly 100 equipment, device and pharmaceutical companies who are involved in radiation therapy. Council seats are balanced between small-, medium- and large-sized corporations, represent a cross section of the radiation oncology industry and are elected positions. The goal of the council is to focus on issues of mutual concern to all corporate members and to increase awareness of radiation therapy and advance the science and practice of radiation therapy in the treatment of cancer.

A complete council listing with term expirations is as follows:
PTW New York - 2009
Elekta/Impac/CMS - 2009
James L. Davis - 2009
BrainLab - 2010
GE Healthcare - 2010
Multidata Systems - 2010
Calypso Medical - 2011
Standard Imaging - 2011
Varian Medical Systems – 2011

For more information: www.astro.org


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now